Search
Descriptor English: Aclarubicin
Descriptor Spanish: Aclarubicina
Descriptor aclarubicina
Entry term(s) aclacinomicina A
Scope note: Antraciclina producida por Streptomyces galilaeus. Tiene una potente actividad antineoplásica.
Descriptor Portuguese: Aclarubicina
Descriptor French: Aclarubicine
Entry term(s): Aclacin
Aclacinomycin A
Aclaplastin
MA 144A1
MA-144A1
MA144A1
NSC 208734
NSC-208734
NSC208734
Tree number(s): D02.455.426.559.847.562.050.050
D04.615.562.050.050
D09.408.051.059.050
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015250
Scope note: An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Number: 74KXF8I502
CAS Type 1 Name: 1-Naphthacenecarboxylic acid,(2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha,2beta,4beta))-
Previous Indexing: Antibiotics, Antineoplastic (1967-1988)
Naphthacenes (1966-1988)
Public MeSH Note: 89
History Note: 89
DeCS ID: 23553
Unique ID: D015250
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1989/01/01
Date of Entry: 1988/05/16
Revision Date: 2016/07/01
Aclarubicin - Preferred
Concept UI M0023487
Scope note An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
Preferred term Aclarubicin
Entry term(s) Aclacinomycin A
NSC-208734 - Narrower
Concept UI M0350661
Preferred term NSC-208734
Entry term(s) NSC 208734
NSC208734
MA-144A1 - Narrower
Concept UI M0350662
Preferred term MA-144A1
Entry term(s) MA 144A1
MA144A1
Aclacin - Narrower
Concept UI M0431771
Preferred term Aclacin
Aclaplastin - Narrower
Concept UI M0431772
Preferred term Aclaplastin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey